CJC-1295 No DAC + Ipamorelin (10mg + 10mg)

$70.00

See all Sizes
5mg + 5mg10mg + 10mg

RESEARCH USE ONLY

10 in stock (can be backordered)

1 Vial
$170.00 Per Vial
$170.00
2 Vials
$161.50 Per Vial (SAVE 5% Per Vial)
$323.00
$340.00
3 Vials
$153.00 Per Vial (SAVE 10% Per Vial)
$459.00
$510.00
4 Vials
$144.50 Per Vial (SAVE 15% Per Vial)
$578.00
$680.00
5 Vials
$136.00 Per Vial (SAVE 20% Per Vial)
$680.00
$850.00
6 Vials
$127.50 Per Vial (SAVE 25% Per Vial)
$765.00
$1,020.00
7 Vials
$119.00 Per Vial (SAVE 30% Per Vial)
$833.00
$1,190.00
8 Vials
$110.50 Per Vial (SAVE 35% Per Vial)
$884.00
$1,360.00
9 Vials
$102.00 Per Vial (SAVE 40% Per Vial)
$918.00
$1,530.00
10 Vials
$93.50 Per Vial (SAVE 45% Per Vial)
$935.00
$1,700.00
Category:

Description

CJC-1295 No DAC + Ipamorelin combines a short-acting GHRH analogue with a selective growth-hormone secretagogue. It is one of the most commonly discussed peptide combinations for research into GH release, IGF-1, and body composition.

Product Information

CJC-1295 No DAC activates GHRH receptors, while ipamorelin acts through GHSR and is designed to stimulate GH release with greater selectivity than older secretagogues.

How Does It Work?

The two peptides stimulate GH release through separate but complementary receptor pathways, creating a combined GH-secretagogue effect.

Benefits

Growth-Hormone Research

CJC-1295 No DAC directly stimulates GHRH receptors, while ipamorelin stimulates the secretagogue pathway, making the combination useful for investigating GH release.

IGF-1 Research

The resulting GH signaling can increase IGF-1, a major mediator of growth-hormone activity in muscle, bone, and connective tissue.

Recovery Research

GH and IGF-1 participate in tissue repair and protein metabolism, which is why this combination is frequently investigated in experimental recovery models.

Body-Composition Research

GH signaling also influences fat metabolism and protein turnover, making the combination relevant to experimental body-composition studies.

Related products